Natural History of Elderly-onset Ulcerative Colitis: Results from a Territory-wide Inflammatory Bowel Disease Registry.

BACKGROUND AND AIMS Data on the natural history of elderly-onset ulcerative colitis [UC] are limited. We aimed to investigate clinical features and outcomes of patients with elderly-onset UC. METHODS Patients with a confirmed diagnosis of UC between 1981 and 2013, from 13 hospitals within a territory-wide Hong Kong Inflammatory Bowel Disease Registry, were included. Clinical features and outcomes of elderly-onset patients, defined as age ≥ 60 years at diagnosis, were compared with those of non-elderly-onset disease [< 60 years at diagnosis]. RESULTS We identified 1225 patients, of whom 12.8% [157/1225; 56.1% male] had elderly-onset UC. Median duration of follow-up was 11 years [interquartile range, 6-16 years]. Age-specific incidence of elderly-onset UC increased from 0.1 per 100000 persons before 1991 to 1.3 per 100000 persons after 2010. There were more ex-smokers [32.2% vs. 12.2%, p < 0.001] and higher proportion of comorbidities [p < 0.001] in elderly-onset than non-elderly-onset patients. Disease extent, corticosteroids, immunosuppressants use, and colectomy rates were similar between the two groups. Elderly-onset disease was an independent risk factor for cytomegalovirus infection [odds ratio 2.9, 95% confidence interval 1.6-5.2, p < 0.001]. More elderly-onset patients had Clostridium difficile infection [11.0% vs. 5.4%, p = 0.007], hospitalisation for UC exacerbation [50.6% vs. 41.8%, p = 0.037], colorectal cancer [3.2% vs. 0.9%, p = 0.033], all-cause mortality [7.0% vs. 1.0%, p < 0.001], and UC-related mortality [1.9% vs. 0.2%, p = 0.017] than non-elderly-onset patients. CONCLUSIONS Elderly-onset UC patients are increasing in number. These patients have higher risk of opportunistic infections, hospitalisation, colorectal cancer, and mortality than non-elderly-onset patients. Management and therapeutic strategies in this special group need careful attention.

[1]  B. Sands,et al.  Early readmission in patients hospitalized for ulcerative colitis: incidence and risk factors , 2015, Scandinavian journal of gastroenterology.

[2]  W. Stremmel,et al.  Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease: a 10-year tertiary referral center experience , 2015, European journal of gastroenterology & hepatology.

[3]  J. Killian,et al.  A model for identifying cytomegalovirus in patients with inflammatory bowel disease. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  P. Munkholm,et al.  Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003-2011—a Danish population-based cohort study. , 2014, Journal of Crohn's & colitis.

[5]  P. Lakatos,et al.  Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. , 2014, Journal of Crohn's & colitis.

[6]  M. Simon Désordres lympho-prolifératifs chez les patients traités par thiopurine pour maladies inflammatoires chroniques intestinales : étude de cohorte observationnelle prospective nationale , 2014 .

[7]  W. Selby,et al.  Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  S. Matsumoto,et al.  What are the factors that affect hospitalization and surgery for aggravation of ulcerative colitis? , 2014, European journal of gastroenterology & hepatology.

[9]  J. Ruel,et al.  IBD across the age spectrum—is it the same disease? , 2014, Nature Reviews Gastroenterology &Hepatology.

[10]  C. Ha,et al.  Clinical implications of ageing for the management of IBD , 2014, Nature Reviews Gastroenterology &Hepatology.

[11]  M. Dave,et al.  Opportunistic Infections Due to Inflammatory Bowel Disease Therapy , 2014, Inflammatory bowel diseases.

[12]  M. Matsuura,et al.  Diagnosis and Treatment of Ulcerative Colitis with Cytomegalovirus Infection: Importance of Controlling Mucosal Inflammation to Prevent Cytomegalovirus Reactivation , 2014, Intestinal research.

[13]  J. Rhodes,et al.  Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit , 2013, Alimentary pharmacology & therapeutics.

[14]  C. Surawicz,et al.  Management of the Elderly Patients with Inflammatory Bowel Disease: Practical Considerations , 2013, Inflammatory bowel diseases.

[15]  H. Ikeuchi,et al.  Prognosis following emergency surgery for ulcerative colitis in elderly patients , 2013, Surgery Today.

[16]  L. Dauchet,et al.  Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study , 2013, Gut.

[17]  D. Hommes,et al.  Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia , 2013, Inflammatory bowel diseases.

[18]  L. Dauchet,et al.  Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[19]  B. Xia,et al.  The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China , 2013, Virology Journal.

[20]  S. Matsumoto,et al.  Ulcerative Colitis: Comparison Between Elderly and Young Adult Patients and Between Elderly Patients with Late-Onset and Long-Standing Disease , 2013, Digestive Diseases and Sciences.

[21]  S. Vermeire,et al.  Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. , 2012, Journal of Crohn's & colitis.

[22]  T. Yau,et al.  Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. , 2012, The Lancet. Oncology.

[23]  B. V. Pedersen,et al.  Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. , 2012, Gastroenterology.

[24]  L. Peyrin-Biroulet,et al.  Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  E. Kuipers,et al.  Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey , 2012, Journal of Gastroenterology.

[26]  A. Zinsmeister,et al.  Outcome of Sporadic Adenomas and Adenoma‐Like Dysplasia in Patients with Ulcerative Colitis Undergoing Polypectomy§† , 2012, Inflammatory bowel diseases.

[27]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.

[28]  G. Kaplan,et al.  Postoperative complications and mortality following colectomy for ulcerative colitis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  G. Kaplan,et al.  Risk of comorbidities on postoperative outcomes in patients with inflammatory bowel disease. , 2011, Archives of surgery.

[30]  M. Taguri,et al.  Clostridium difficile infection in patients with ulcerative colitis: investigations of risk factors and efficacy of antibiotics for steroid refractory patients. , 2011, Clinics and research in hepatology and gastroenterology.

[31]  P. Lakatos,et al.  IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. , 2011, Journal of Crohn's & colitis.

[32]  J. Stockman Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study , 2011 .

[33]  S. Danese,et al.  Ulcerative colitis. , 2011, The New England journal of medicine.

[34]  V. Annese,et al.  Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[35]  R. Newberry,et al.  Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  J. Satsangi,et al.  PWE-029 Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis , 2010, Gut.

[37]  T. Kim,et al.  Do Patients with Ulcerative Colitis Diagnosed at a Young Age Have More Severe Disease Activity than Patients Diagnosed when Older? , 2010, Digestion.

[38]  A. Zinsmeister,et al.  Risk factors for opportunistic infections in patients with inflammatory bowel disease. , 2008, Gastroenterology.

[39]  G. Kaplan,et al.  Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. , 2008, Gastroenterology.

[40]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[41]  A. Ananthakrishnan,et al.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease , 2007, Gut.

[42]  Clarence K. Wong,et al.  Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[43]  A. Zinsmeister,et al.  Risk Factors for Colorectal Neoplasia in Inflammatory Bowel Disease: A Nested Case–Control Study From Copenhagen County, Denmark and Olmsted County, Minnesota , 2007, The American Journal of Gastroenterology.

[44]  Jun Kato,et al.  Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000 , 2007, European journal of gastroenterology & hepatology.

[45]  J. Satsangi,et al.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.

[46]  Simon Smale,et al.  Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  M. Vieth,et al.  Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment , 2005, Gut.

[48]  R. D'Incà,et al.  Age-Related Clinical Severity at Diagnosis in 1705 Patients with Ulcerative Colitis , 2000, Digestive Diseases and Sciences.

[49]  P. Munkholm,et al.  Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. , 2003, Gastroenterology.

[50]  J. Triantafillidis,et al.  Ulcerative colitis in the elderly: clinical patterns and outcome in 51 Greek patients , 2001, Journal of Gastroenterology.

[51]  R. Parker,et al.  Corticosteroid-associated complications in elderly Crohn's disease patients. , 1997, The American journal of gastroenterology.

[52]  J. Lennard-jones,et al.  Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.

[53]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[54]  C. FordAlexander,et al.  ULCERATIVE colitis. , 1997, Journal of the American Medical Association.

[55]  S. Truelove,et al.  Cortisone in Ulcerative Colitis , 1954 .